APAF1 and B-cell non-Hodgkin lymphoma: These data, albeit with a small number of samples, point to a possible correlation between membrane localization of Apaf-1 and BCL11A overexpression [26, 27], which could serve as novel indicator of drug resistance or poor prognosis in B cell lymphomas.